165 related articles for article (PubMed ID: 21894099)
1. Unusual presentation of a patient with GBL withdrawal: a case report.
Kashyap GL; Patel AG
Psychiatr Danub; 2011 Sep; 23 Suppl 1():S32-4. PubMed ID: 21894099
[TBL] [Abstract][Full Text] [Related]
2. A case of γ-butyrolactone associated with severe withdrawal delirium and acute renal failure.
Bhattacharya IS; Watson F; Bruce M
Eur Addict Res; 2011; 17(4):169-71. PubMed ID: 21454980
[TBL] [Abstract][Full Text] [Related]
3. Medical and legal confusion surrounding gamma-hydroxybutyrate (GHB) and its precursors gamma-butyrolactone (GBL) and 1,4-butanediol (1,4BD).
Wood DM; Warren-Gash C; Ashraf T; Greene SL; Shather Z; Trivedy C; Clarke S; Ramsey J; Holt DW; Dargan PI
QJM; 2008 Jan; 101(1):23-9. PubMed ID: 18203723
[TBL] [Abstract][Full Text] [Related]
4. Pentobarbital for severe gamma-butyrolactone withdrawal.
Sivilotti ML; Burns MJ; Aaron CK; Greenberg MJ
Ann Emerg Med; 2001 Dec; 38(6):660-5. PubMed ID: 11719746
[TBL] [Abstract][Full Text] [Related]
5. [Acute gamma-butyrolactone poisoning with withdrawal syndrome].
Chwaluk P; Rejmak G
Przegl Lek; 2011; 68(8):537-8. PubMed ID: 22010460
[TBL] [Abstract][Full Text] [Related]
6. Neuroleptic malignant syndrome-like reaction precipitated by antipsychotics in a patient with gamma-butyrolactone withdrawal.
Eiden C; Capdevielle D; Deddouche C; Boulenger JP; Blayac JP; Peyrière H
J Addict Med; 2011 Dec; 5(4):302-3. PubMed ID: 21817917
[TBL] [Abstract][Full Text] [Related]
7. [First report of lethal gamma-hydroxybutyrate (GHB) intoxication after consumption of gamma-butyrolactone (GBL) in Lower Saxony].
Fieguth A; Albrecht K; Weller JP; Kühnle R; Teske J
Arch Kriminol; 2009; 223(1-2):45-51. PubMed ID: 19323150
[TBL] [Abstract][Full Text] [Related]
8. [GHB withdrawal delirium].
Stijnenbosch PJ; Zuketto C; Beijaert PJ; Maat A
Ned Tijdschr Geneeskd; 2010; 154():A1086. PubMed ID: 20132572
[TBL] [Abstract][Full Text] [Related]
9. Gamma hydroxybutyrate (GHB) and gamma butyrolactone (GBL) withdrawal: five case studies.
McDaniel CH; Miotto KA
J Psychoactive Drugs; 2001; 33(2):143-9. PubMed ID: 11476261
[TBL] [Abstract][Full Text] [Related]
10. Management and treatment of gamma butyrolactone withdrawal syndrome: a case report and review.
Ghio L; Cervetti A; Respino M; Belvederi Murri M; Amore M
J Psychiatr Pract; 2014 Jul; 20(4):294-300. PubMed ID: 25036586
[TBL] [Abstract][Full Text] [Related]
11. Gamma-butyrolactone (GBL) dependence and withdrawal.
Bell J; Collins R
Addiction; 2011 Feb; 106(2):442-7. PubMed ID: 20925687
[TBL] [Abstract][Full Text] [Related]
12. Gamma-hydroxybutyrate withdrawal syndrome: dangerous but not well-known.
van Noorden MS; van Dongen LC; Zitman FG; Vergouwen TA
Gen Hosp Psychiatry; 2009; 31(4):394-6. PubMed ID: 19555805
[TBL] [Abstract][Full Text] [Related]
13. Gamma-hydroxybutyrate withdrawal syndrome.
Dyer JE; Roth B; Hyma BA
Ann Emerg Med; 2001 Feb; 37(2):147-53. PubMed ID: 11174231
[TBL] [Abstract][Full Text] [Related]
14. [Abuse of γ-hydroxybutyrate].
Bramness JG; Haugland S
Tidsskr Nor Laegeforen; 2011 Nov; 131(21):2122-5. PubMed ID: 22048208
[TBL] [Abstract][Full Text] [Related]
15. A 16-year-old boy with severe gamma-butyrolactone (GBL) withdrawal delirium.
Zepf FD; Holtmann M; Duketis E; Maier J; Radeloff D; Wagner A; Poustka F; Wöckel L
Pharmacopsychiatry; 2009 Sep; 42(5):202-3. PubMed ID: 19724983
[No Abstract] [Full Text] [Related]
16. Acute toxicity and withdrawal syndromes related to γ-hydroxybutyrate (GHB) and its analogues γ-butyrolactone (GBL) and 1,4-butanediol (1,4-BD).
Wood DM; Brailsford AD; Dargan PI
Drug Test Anal; 2011; 3(7-8):417-25. PubMed ID: 21548140
[TBL] [Abstract][Full Text] [Related]
17. Intoxication by gamma hydroxybutyrate and related analogues: Clinical characteristics and comparison between pure intoxication and that combined with other substances of abuse.
Miró Ò; Galicia M; Dargan P; Dines AM; Giraudon I; Heyerdahl F; Hovda KE; Yates C; Wood DM; Liakoni E; Liechti M; Jürgens G; Pedersen CB; O'Connor N; Markey G; Moughty A; Lee C; O'Donohoe P; Sein Anand J; Puiguriguer J; Homar C; Eyer F; Vallersnes OM; Persett PS; Chevillard L; Mégarbane B; Paasma R; Waring WS; Põld K; Rabe C; Kabata PM
Toxicol Lett; 2017 Aug; 277():84-91. PubMed ID: 28579487
[TBL] [Abstract][Full Text] [Related]
18. Clinical management of gamma-hydroxybutyrate (GHB) withdrawal delirium with CIWA-Ar protocol.
Liao PC; Chang HM; Chen LY
J Formos Med Assoc; 2018 Dec; 117(12):1124-1127. PubMed ID: 29933901
[TBL] [Abstract][Full Text] [Related]
19. Withdrawal akathisia: case reports and a proposed classification of chronic akathisia.
Lang AE
Mov Disord; 1994 Mar; 9(2):188-92. PubMed ID: 8196681
[TBL] [Abstract][Full Text] [Related]
20. Withdrawal from gamma-hydroxybutyrate, 1,4-butanediol and gamma-butyrolactone: a case report and systematic review.
Wojtowicz JM; Yarema MC; Wax PM
CJEM; 2008 Jan; 10(1):69-74. PubMed ID: 18226321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
